Try our Advanced Search for more refined results

In Re Vitamin C Antitrust Liti

  1. August 12, 2014

    Vitamin C Makers, Buyers Fire Closing Salvos In 2nd Circ.

    The parties in a vitamin C price-fixing class action fired off their final briefs in the Second Circuit on Monday, volleying over the case's effect on Chinese sovereignty and the reach China's government had in compelling the collusive scheme, among other things.

  2. July 22, 2014

    Vitamin C Makers Tell 2nd Circ. To Uphold Chinese Law

    North China Pharmaceuticals Group Corp. and HeBei Welcome Pharmaceuticals Co. on Monday told the Second Circuit that reversal of a verdict against them in a vitamin C price-fixing class action was necessary because the purchasers who brought the suit admitted that the companies' coordination was required by Chinese law.

  3. July 08, 2014

    Vitamin C Buyers Tell 2nd Circ. To Uphold $153M Award

    Purchasers of vitamin C products on Monday urged the Second Circuit to reject a bid by two Chinese companies to reverse a $153 million award against them over price-fixing claims, arguing they lack any evidence to show they were compelled to fix prices by the Chinese government.

  4. May 27, 2014

    China Asks US To Back Vitamin C Antitrust Appeal In 2nd Circ.

    The Chinese government has asked the U.S. State Department to support China's efforts to convince the Second Circuit to overturn a $153 million price-fixing award against Chinese vitamin C producers, according to a diplomatic note filed in the class action on Friday.

  5. April 16, 2014

    China's Challenge To Vitamin C Price-Fixing Ruling On Point

    The Chinese government went into the Second Circuit on Monday with guns blazing, accusing a U.S. judge of implying that Chinese officials covered up price-fixing by vitamin C companies and blatantly ignoring China's explanation of its own laws in violation of U.S. Supreme Court precedent. And while that may sound extreme, attorneys say the country appears to have gotten it right.

  6. April 08, 2014

    2nd Circ. Asked To Reverse $153M Vitamin C Antitrust Award

    North China Pharmaceuticals Group Corp. and HeBei Welcome Pharmaceuticals Co. on Tuesday urged the Second Circuit to reverse a $153 million award against them in a class action over vitamin C price-fixing claims, arguing that the trial court disregarded Chinese laws that compelled them to engage in the alleged antitrust violations.

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!